Percutaneous microwave ablation versus sclerotherapy for large hepatic hemangioma: a multi-center cohort study

The study aimed to compare the effectiveness and safety of ultrasound-guided microwave ablation (MWA) and percutaneous sclerotherapy (PS) for the treatment of large hepatic hemangioma (LHH). This retrospective study included 96 patients who underwent MWA (  = 54) and PS (  = 42) as first-line treatm...

Full description

Saved in:
Bibliographic Details
Published in:International journal of hyperthermia 2024, Vol.41 (1), p.2285705-2285705
Main Authors: Cai, Qian, Qian, Tong-Gang, Zhao, Qi-Yu, Feng, Shun-You, Yang, Qiao, Luo, Yan-Chun, Dai, Yu-Qing, Liang, Ping, Yu, Xiao-Ling, Liu, Fang-Yi, Han, Zhi-Yu, Du, Qiao-Wei, Li, Xin, Yu, Jie
Format: Article
Language:eng
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The study aimed to compare the effectiveness and safety of ultrasound-guided microwave ablation (MWA) and percutaneous sclerotherapy (PS) for the treatment of large hepatic hemangioma (LHH). This retrospective study included 96 patients who underwent MWA (  = 54) and PS (  = 42) as first-line treatment for LHH in three tertiary hospitals from January 2016 to December 2021. Primary outcomes were technique efficacy rate (volume reduction rate [VRR] > 50% at 12 months), symptom relief rate at 12 months and local tumor progression (LTP). Secondary outcomes included procedure time, major complications, treatment sessions, cost and one-, two-, three-year VRR. During a median follow-up of 36 months, the MWA group showed a higher technique efficacy rate (100% vs. 90.4%,  = .018) and symptom relief rate (100% vs. 80%,  = .123) than the PS group. The MWA group had fewer treatment sessions, higher one-, two- and three-year VRR, lower LTP rate (all  
ISSN:0265-6736
1464-5157